COLL vs MCO · P/E 17, rev $181.9M vs P/E 33, rev $7.72B
Collegium Pharmaceutical Inc (COLL) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the COLL and MCO stock pages for the full models.
Not investment advice.